[go: up one dir, main page]

ES2129401T3 - Uso de un compuesto terapeutico para el tratamiento de bronquitis. - Google Patents

Uso de un compuesto terapeutico para el tratamiento de bronquitis.

Info

Publication number
ES2129401T3
ES2129401T3 ES91304449T ES91304449T ES2129401T3 ES 2129401 T3 ES2129401 T3 ES 2129401T3 ES 91304449 T ES91304449 T ES 91304449T ES 91304449 T ES91304449 T ES 91304449T ES 2129401 T3 ES2129401 T3 ES 2129401T3
Authority
ES
Spain
Prior art keywords
treatment
bronchitis
therapeutic compound
ofbronchitis
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91304449T
Other languages
English (en)
Inventor
Mitchell Glass
Joseph Campbell Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Application granted granted Critical
Publication of ES2129401T3 publication Critical patent/ES2129401T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE FACILITA UN NUEVO COMPUESTO TERAPEUTICO PARA SU USO EN EL TRATAMIENTO SINTOMATICO DE LA BRONQUITIS Y PARA SU USO EN LA PREPARACION DE UN MEDICAMENTO PARA EL TRATAMIENTO DE LA BRONQUITIS, ASI COMO UN METODO DE TRATAMIENTO DE LA BRONQUITIS CON EL COMPUESTO TERAPEUTICO Y UN METODO DE TRATAMIENTO DE LA BRONQUITIS CON EL COMPUESTO TERAPEUTICO JUNTO CON UNO O MAS AGENTES DISTINTOS INDICADOS PARA EL TRATAMIENTO DE LA BRONQUITIS.
ES91304449T 1990-05-24 1991-05-17 Uso de un compuesto terapeutico para el tratamiento de bronquitis. Expired - Lifetime ES2129401T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52865790A 1990-05-24 1990-05-24

Publications (1)

Publication Number Publication Date
ES2129401T3 true ES2129401T3 (es) 1999-06-16

Family

ID=24106599

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91304449T Expired - Lifetime ES2129401T3 (es) 1990-05-24 1991-05-17 Uso de un compuesto terapeutico para el tratamiento de bronquitis.

Country Status (12)

Country Link
EP (1) EP0458537B1 (es)
JP (1) JPH04235133A (es)
AT (1) ATE178336T1 (es)
AU (1) AU648078B2 (es)
CA (1) CA2043107A1 (es)
DE (1) DE69131058T2 (es)
DK (1) DK0458537T3 (es)
ES (1) ES2129401T3 (es)
GR (1) GR3029726T3 (es)
IE (1) IE911698A1 (es)
IL (1) IL98200A0 (es)
ZA (1) ZA913920B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162348A (en) * 1990-05-24 1992-11-10 Imperial Chemical Industries Plc Treatment of cystic fibrosis
DE69129083T2 (de) * 1990-05-24 1998-07-09 Zeneca Ltd Therapeutisches Mittel zur Vorbeugung und Behandlung des Atemnotsyndroms bei Erwachsenen
GB9113164D0 (en) * 1991-06-18 1991-08-07 Ici Plc Pharmaceutical agent
DE10138294C5 (de) * 2001-08-10 2006-09-28 Db Netz Ag Verfahren und Vorrichtung zum Auswechseln eines Fahrdrahtes an einer Oberleitung

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0182906A1 (en) * 1984-06-14 1986-06-04 Cortech, Inc. Human leukocyte elastase inhibitors prepared from pyogenic bacteria and methods for their purification
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
EP0276101A3 (en) * 1987-01-19 1989-11-23 Ici Americas Inc. Substituted peptide derivatives
GB8809316D0 (en) * 1987-05-11 1988-05-25 Ici America Inc Heterocyclic ketones
GB8808701D0 (en) * 1988-04-13 1988-05-18 Erba Carlo Spa Beta-lactam derivatives
DE68925923T2 (de) * 1988-06-10 1996-11-14 Merck & Co Inc Antigene der einzigen Spaltungsstelle von Fibrinogen durch Elastase
EP0369391A3 (en) * 1988-11-15 1991-09-25 Boehringer Ingelheim Pharmaceuticals Inc. N-substituted amides
NO177716C (no) * 1989-06-09 1995-11-08 Zeneca Ltd Fremgangsmåte for fremstilling av terapeutisk aktive polypeptider, DNA-sekvens, ekspresjonsvektor og antistoff
US5162348A (en) * 1990-05-24 1992-11-10 Imperial Chemical Industries Plc Treatment of cystic fibrosis

Also Published As

Publication number Publication date
IL98200A0 (en) 1992-06-21
EP0458537B1 (en) 1999-03-31
IE911698A1 (en) 1991-12-04
DE69131058D1 (de) 1999-05-06
AU648078B2 (en) 1994-04-14
CA2043107A1 (en) 1991-11-25
GR3029726T3 (en) 1999-06-30
ZA913920B (en) 1992-02-26
EP0458537A3 (en) 1992-07-08
EP0458537A2 (en) 1991-11-27
ATE178336T1 (de) 1999-04-15
DK0458537T3 (da) 1999-10-18
DE69131058T2 (de) 1999-09-09
JPH04235133A (ja) 1992-08-24
AU7719491A (en) 1991-11-28

Similar Documents

Publication Publication Date Title
EP0453127A3 (en) Treatment of cataract with 15-keto-prostaglandin compounds
GR3019179T3 (en) Flupirtine in combination with antiparkinsonica against muscle bracing
ES2055587T3 (es) El uso de agonistas selectivos de gaba-b como agentes antitusivos.
DE68910799D1 (de) Faserbehandlungszusammensetzung.
ES2093774T3 (es) Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.
DE69130586D1 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
ATE133663T1 (de) Antiglancoma-zusammensetzungen enthaltend 3- arylcarbonyl-1-aminoalkyl-1h-indol
ES2013631B3 (es) Metodo para el tratamiento de tejidos.
EP0467564A3 (en) Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.
DK0458589T3 (da) Behandling af okulær hypertension med en okulær synergistisk kombination
EP0424156A3 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
ES2129401T3 (es) Uso de un compuesto terapeutico para el tratamiento de bronquitis.
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DE69116224D1 (de) Behandlung von intraokularem Druck mit einer synergischen Kombination
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
ES2055421T3 (es) Uso de clormetiazol en la fabricacion de un medicamento para la prevencion y/o el tratamiento de neurodegeneracion.
DK452788A (da) Smertestillende praeparat
MX9203089A (es) Composicion para el tratamiento de esquisofrenia.
GB8428552D0 (en) Organic compounds
UA8506A1 (uk) Ціаhиhові сполуки як компоhеhт фоторезисту світлопоглиhаючого у видимій частиhі спектра
MX9203508A (es) 1,7-difenil-3-metilaza -7-ciano-8-metilnonano para usarse en el tratamiento de enfermedades.
ES2025787T3 (es) Procedimiento de tratamiento de madera.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 458537

Country of ref document: ES